The aortic valve, normally consisting of 3 leaflets, opens during ventricular systole and closes during diastole. Valve closure prevents backflow of blood from the aorta to the left ventricle (LV) and helps maintain aortic diastolic pressure and coronary perfusion pressure.
Aortic regurgitation (AR) is the presence of a backflow leak through the valvular apparatus during diastole.
Ranges in severity from trace, mild, moderate, or severe; it is classified by the amount of regurgitant volume, regurgitant orifice area size, and pressure equalization half-time by echocardiography.
Regurgitation may be associated with any condition that alters aortic valve closure. Aortic dilation, aneurysm, dissection, and abscess are external causes of aortic valve dysfunction and account for about half of all AR cases. Rheumatic valve disease, collagen vascular diseases, connective tissue diseases (especially Marfan syndrome (1) [C]), congenital malformations, senile degeneration, and infective endocarditis are direct valvular conditions that commonly produce AR in the remainder of cases.
Acute AR is the sudden onset of backflow leak usually due to an acute event such as aortic dissection or valvular trauma.
Chronic AR has a gradual onset and may be sustained for many years.
May also accompany aortic stenosisa narrowing of the open valvular area
Epidemiology
Incidence
Worldwide, rheumatic heart disease is the most common cause of AR.
In the US, congenital and degenerative valvular and aortic disease is most common.
Congenital bicuspid aortic valves occur in 12% of the US population and may contribute to AR.
Prevalence
13% in men, 8.5% in women in a Framingham study (2)
Acute AR has a higher rate of morbidity and mortality due to the underlying pathophysiology. This can result in diastolic and systolic dysfunction and eventually decompensation (CHF).
Chronic AR mortality is related to the eventual decompensation of the LV; it is more common in severe AR. Decreased ejection fraction and LV function have a poor prognosis for recovery, even after repair.
Surgical management becomes the common end point to both types of AR.
Mortality
Acute AR has a high mortality due to sudden uncompensated cardiovascular changes usually requiring immediate surgical management.
Chronic AR mortality relates to eventual decompensation of the LV and may occur at any age usually with severe AR. Decreased ejection fraction and LV function has a poor prognosis for recovery even after repair.
Yearly mortality risk relates to NYHA classification for chronic severe AR:
Male gender has a greater risk for AR with a related increased risk of hypertension, connective tissue and congenital valvular diseases, which may result in presentation at a younger age.
Severe AR is most commonly diagnosed at age 60 and above.
Physiology/Pathophysiology
Acute AR results in an acute increase in LV diastolic volume, decreased aortic diastolic pressure (forward flow), decreased coronary perfusion pressure, volume overload, and decreased diastolic function of the LV. This leads to an increase in myocardial demand, acute fulminant CHF, and cardiogenic shock. Common causes of acute AR, including aortic dissection, warrant emergent surgical repair.
Chronic AR has a more insidious onset and may take years to become symptomatic. As regurgitant volume and AR worsen over time, the LV has time to remodel with eccentric hypertrophy and dilation. The increase in diastolic volume is compensated by the enlarged LV, increased heart rate, and decreased systemic vascular resistance (SVR). Ejection fraction is maintained and may prevent symptoms without exertion or positional changes. As time passes, the ventricle becomes "too enlarged" with resultant increases in wall stress and decreases in myocardial perfusion (leads to diminished EF, CHF, and end-organ hypoperfusion). Recall Laplace's law where Tension = (Pressure × Radius)/Wall Thickness; as the radius increases, tension also increases (increases myocardial oxygen consumption). Sympathetic stimulation increases SVR to maintain pressure but worsens AR; hinders forward flow. Without timely surgical repair the heart may not be able to significantly recover.
Anesthetic GOALS/GUIDING Principles
Maintenance of cardiac output, coronary perfusion, and prevention of cardiac decompensation are the primary goals.
Normal sinus rhythm and avoidance of bradycardia to minimize regurgitant time
SVR may be mildly decreased, but should be balanced between facilitating forward flow (decreasing regurgitation) and maintaining adequate coronary and systemic perfusion pressure.
Careful fluid management and inotropic support to prevent cardiovascular overload or collapse
Midazolam to prevent anxiety and increased sympathetic tone, as appropriate
Special Concerns for Informed Consent
Risk for intraoperative stroke, myocardial infarction, and death should be discussed.
INTRAOPERATIVE CARE
Choice of Anesthesia
Depends on the procedure; sedation, general (endotracheal tube or laryngeal mask airway) and regional anesthesia may be utilized.
Neuraxial techniques can result in a sympathectomy and facilitate forward flow (reduce regurgitation), but may reduce coronary perfusion pressure.
Monitors
Standard ASA monitors
Invasive monitors may be chosen based upon the severity of AR and the surgical procedure.
Induction/Airway Management
Smooth, controlled induction to maintain vital signs within normal limits
Anticholinergic medications may be administered to maintain a NSR and slightly increase the heart rate.
Maintenance
Volatile and/or intravenous anesthetics may be utilized. Reductions in SVR are desirable to facilitate forward flow; however, adequate cerebral and coronary perfusion should be ensured. Total intravenous techniques may be associated with bradycardia, particularly if utilizing high doses of remifentanil.
Fluid balance includes maintaining normal preload and hematocrit >2430 g/dL to optimize forward flow and myocardial oxygen balance. Excessive preload may add to regurgitant volume and cause LV failure.
OdiliAN, AmusaGA.Aortic aneurysm with valvular insufficiency: Is it due to Marfan syndrome or hypertension? A case report and review of literature. J Vasc Nurs. 2011;29(1):1622.
SinghJP, EvansJC, LevyD,et al. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation. Am J Cardiol. 1999;83:897902.
DujardinKS, Enriquez-SaranoM, SchaffHV, et al.Mortality and morbidity of aortic regurgitation in clinical practice: A long-term follow-up study. Circulation. 1999;99(14):18511857.
Aortic regurgitation (AR) is most commonly an acquired disease but may be related to congenital malformations and several systemic conditions such as Marfan syndrome.
Significant signs and symptoms include shortness of breath, angina, syncope, and systolic and diastolic congestive heart failure with eccentric hypertrophy and a dilated LV.
Severity is classified by echocardiographic criteria; 60 mL or 50% regurgitant volume being severe AR.
Acute AR is life-threatening and often requires immediate surgical management.
Chronic AR requires medical or surgical management and may be asymptomatic until late stages. Symptomatic, severe AR with below normal LV EF requires urgent treatment and has poorer prognosis.